Today, the New England Journal of Medicine is publishing a Perspective article written by Hans Hogerzeil. The article sets out the methods of the Access to Medicine Index, touching upon the 2012 Index’ key findings and trends.
Moreover, Professor Hogerzeil highlights the value of the Index, emphasizing the movement of companies towards fulfilling, in his own words, the “wish list for company behavior” for improving access to medicine. Read more about what he refers to as “the real potential of the Index” in the article “Big Pharma and Social Responsibility – The Access to Medicine Index”.
Hans V. Hogerzeil is a Professor of Global Health at the University Medical Centre Groningen, University of Groningen, the Netherlands. He is currently the acting chair of the Supervisory Board of the Access to Medicine Foundation and also chairs the Expert Review Committee for the 2014 Access to Medicine Index. Please find his profile here.